Description
Human Lyn Protein Active
| Catalog number: | B2014241 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 5 g |
| Molecular Weight or Concentration: | 59.6 kDa |
| Supplied as: | Solution |
| Applications: | molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | Lyn Protein, active |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Song W, Li D, Tao L, Luo Q, Chen L. Solute carrier transporters: the metabolic gatekeepers of immune cells Acta Pharm Sin B. 2020 Jan;10(1):61-78.
- Ingley E. Functions of the Lyn tyrosine kinase in health and disease Cell Commun Signal. 2012 Jul 17;10(1):21.
- Ding Y, Wang Y, Li C, Zhang Y, Hu S, Gao J, Liu R, An H. -Linolenic acid attenuates pseudo-allergic reactions by inhibiting Lyn kinase activity Phytomedicine. 2021 Jan;80:153391.
- Munshi N, Ganju RK, Avraham S, Mesri EA, Groopman JE. Kaposis sarcoma-associated herpesvirus-encoded G protein-coupled receptor activation of c-jun amino-terminal kinase/stress-activated protein kinase and lyn kinase is mediated by related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2 J Biol Chem. 1999 Nov 5;274(45):31863-7.
- Torigoe T, OConnor R, Santoli D, Reed JC. Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines Blood. 1992 Aug 1;80(3):617-24.
- Lu WJ, Wu MP, Lin KH, Lin YC, Chou HC, Sheu JR. Hinokitiol is a novel glycoprotein VI antagonist on human platelets Platelets. 2014;25(8):595-602.
- Takeshita H, Taniuchi I, Kato J, Watanabe T. Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene Int Immunol. 1998 Apr;10(4):435-44.
- Kasela T, Dbala M, Mistarz M, Wieczorek W, Wierzbik-Stroska M, Boro K, Zawidlak-Wgrzyska B, Oskar Grabarek B. Effects of Cyclosporine A and Adalimumab on the expression profiles histaminergic system-associated genes and microRNAs regulating these genes in HaCaT cells Cell Cycle. 2022 Dec;21(23):2499-2516.
- Guerrouahen BS, Futami M, Vaklavas C, Kanerva J, Whichard ZL, Nwawka K, Blanchard EG, Lee FY, Robinson LJ, Arceci R, Kornblau SM, Wieder E, Cayre YE, Corey SJ. Dasatinib inhibits the growth of molecularly heterogeneous myeloid leukemias Clin Cancer Res. 2010 Feb 15;16(4):1149-58.
